
|Articles|July 24, 2017
Reagan-Udall Foundation for FDA Launches Navigator Website
Advertisement
Reagan-Udall Foundation, the non-profit foundation for the FDA, launched a new website called Expanded Access Navigator. It features a pharma company directory of expanded access policies and criteria, along with educational resources, guides, and downloadable forms.
The American Cancer Society, the American Society of Clinical Oncology, the Biotechnology Industry Association, FDA, Foundation Medicine, PhRMA and Susan G. Komen helped develop the Navigator along with the support of Bristol-Meyers Squibb, Genentech, Janssen, Lilly, Merck and Pfizer.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5



